13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q3 2017. See the latest, Q3 2026 →
Reported value
$8.02B
−8.3% on the quarter before
Positions
37
5 new, 9 sold out
Top 10
78.1%
of the value
Est. gain
−$300.4M
on stocks held all quarter
Est. return
−3.8%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, sized at quarter-end prices.
- Allergan Plc~$109.0MAdded, 6.8% → 7.6% of the portfolio+531,600 shares
- Mckesson Corp~$76.8MNew, 0.0% → 1.0% of the portfolio+500,000 shares
- Antero Res Corp~$54.6MAdded, 5.2% → 5.9% of the portfolio+2,741,261 shares
- Amc Entmt Hldgs Inc~$52.4MNew, 0.0% → 0.7% of the portfolio+3,565,361 shares
- Cardinal Health Inc~$33.5MAdded, 1.8% → 2.1% of the portfolio+500,000 shares
- Amerisourcebergen Corp~$15.6MNew, 0.0% → 0.2% of the portfolio+188,850 shares
- Pioneer Nat Res Co~$4.3MNew, 0.0% → 0.1% of the portfolio+28,895 shares
- Twenty First Centy Fox Inc~$2.7MAdded, 2.3% → 2.4% of the portfolio+106,442 shares
- Simply Good Foods Co~$2.5MNew, 0.0% → 0.0% of the portfolio+1,035,146 shares
- Theravance Biopharma Inc~$1.2MAdded, 4.2% → 4.0% of the portfolio+35,177 shares
Largest sells
Since Q2 2017, sized at quarter-end prices.
- Qualcomm~$288.0MSold out, 3.3% → 0.0% of the portfolio−5,216,000 shares
- Dell Technologies Inc~$200.7MCut, 3.9% → 2.9% of the portfolio−2,600,000 shares
- Avis Budget Group~$112.8MCut, 1.2% → 0.5% of the portfolio−2,963,100 shares
- Spirit Rlty Cap Inc New~$66.7MSold out, 0.8% → 0.0% of the portfolio−9,000,000 shares
- Silver Run Acquisition~$45.5MCut, 0.8% → 0.3% of the portfolio−4,466,200 shares
- Conyers Pk Acquisition~$43.7MSold out, 0.5% → 0.0% of the portfolio−3,712,500 shares
- Liberty Media Corp Delaware~$31.2MSold out, 0.4% → 0.0% of the portfolio−1,303,482 shares
- Credit Accep Corp Mich~$25.4MSold out, 0.3% → 0.0% of the portfolio−98,700 shares
- Theravance Inc~$15.5MSold out, 0.2% → 0.0% of the portfolio−16,980,000 shares
- ChipMOS Technologies~$8.9MCut, 0.8% → 0.7% of the portfolio−461,563 shares
Holdings
As of Sep 30, 2017; changes in shares since Jun 30, 2017.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cheniere Energy IncCOM NEW · shares 0% · price −7.5% | 11.6% | $933.5M | −$76.1M | ||||||
| Synchrony FinlCOM · shares 0% · price +4.1% | 11.3% | $909.6M | +$36.0M | ||||||
| Viasat IncCOM · shares 0% · price −2.8% | 10.5% | $846.3M | −$24.7M | ||||||
| QorvoCOM · shares 0% · price +11.6% | 7.9% | $636.1M | +$66.2M | ||||||
| Allergan PlcSHS · shares +22% · price −15.7% | 7.6% | $607.5M | −$92.8M | ||||||
| Colony Northstar IncCL A COM · shares 0% · price −10.9% | 7.5% | $601.7M | −$73.3M | ||||||
| Twenty First Centy Fox IncCL A · shares 0% · price −6.9% | 6.3% | $504.8M | −$37.5M | ||||||
| Antero Res CorpCOM · shares +13% · price −7.9% | 5.9% | $475.9M | −$36.2M | ||||||
| Pbf Energy IncCL A · shares 0% · price +24.0% | 5.4% | $434.1M | +$84.1M | ||||||
| Theravance Biopharma IncCOM · shares +0.4% · price −14.1% | 4.0% | $318.7M | −$51.9M | ||||||
| Dell Technologies IncCOM CL V · shares −46% · price +26.3% | 2.9% | $235.7M | +$49.1M | ||||||
| Twenty First Centy Fox IncCL B · shares +1.5% · price −7.5% | 2.4% | $190.4M | −$15.1M | ||||||
| Keryx Biopharmaceuticals IncCOM · shares 0% · price −1.8% | 2.3% | $183.1M | −$3.4M | ||||||
| Cardinal Health IncCOM · shares +25% · price −14.1% | 2.1% | $169.3M | −$22.3M | ||||||
| Express Scripts Hldg CoCOM · shares 0% · price −0.8% | 2.0% | $161.9M | −$1.3M | ||||||
| Veritiv CorpCOM · shares +0.3% · price −27.8% | 1.2% | $99.2M | −$38.1M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price +18.2% | 1.1% | $88.7M | +$13.7M | ||||||
| Mckesson CorpCOM · shares New | 0.96% | $76.8M | — | ||||||
| Paratek Pharmaceuticals IncCOM · shares 0% · price +4.2% | 0.75% | $60.1M | +$2.4M | ||||||
| ChipMOS TechnologiesSPONSORED ADR · shares −13% · price −2.3% | 0.73% | $58.9M | −$1.4M | ||||||
| Amc Entmt Hldgs IncCL A COM · shares New | 0.65% | $52.4M | — | ||||||
| Gty Technology Holdings IncUNIT 99/99/9999 · shares 0% · price 0.0% | 0.57% | $46.0M | $0.00 | ||||||
| Centennial Resource Dev IncCL A · shares 0% · price +14.5% | 0.52% | $42.1M | +$5.3M | ||||||
| Avis Budget GroupCOM · shares −74% · price +39.6% | 0.49% | $39.5M | +$11.2M | ||||||
| Forward Pharma A/SSPONSORED ADR · shares +1.6% · price −70.1% | 0.49% | $39.2M | −$90.8M | ||||||
| Total 37 positions | 100% | $8.02B | −$300.4M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 31 stocks held throughout, down $300.4M (−3.8%).
- Pbf Energy Inc+$84.1M+24%
- Qorvo+$66.2M+12%
- Dell Technologies Inc+$49.1M+26%
- Synchrony Finl+$36.0M+4%
- Atara Biotherapeutics Inc+$13.7M+18%
- Theravance Biopharma Inc−$51.9M−14%
- Colony Northstar Inc−$73.3M−11%
- Cheniere Energy Inc−$76.1M−8%
- Forward Pharma A/S−$90.8M−70%
- Allergan Plc−$92.8M−16%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |